Otsuka’s Lupkynis receives NICE green light by John Pinching | May 3, 2023 | News | 0 Recommendation applies across England and Wales and the treatment is available now Read More
Otsuka receives vital Lupkynis MHRA authorisation by John Pinching | Nov 30, 2022 | News | 0 Therapy represents first oral calcineurin-inhibitor treatment for active lupus nephritis in adults Read More
Aurinia receives positive CHMP opinion for Lupkynis by John Pinching | Jul 25, 2022 | News | 0 Therapy effectively treats adults with active lupus nephritis in Europe Read More